These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17451840)

  • 1. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.
    Meade BR; Dowdy SF
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):134-40. PubMed ID: 17451840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB; Pereira MP; Kelley SO
    Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA delivery using peptide transduction domains.
    Eguchi A; Dowdy SF
    Trends Pharmacol Sci; 2009 Jul; 30(7):341-5. PubMed ID: 19545914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
    Chugh A; Eudes F; Shim YS
    IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery of siRNA therapeutics: potentials and limits of nanosystems.
    Reischl D; Zimmer A
    Nanomedicine; 2009 Mar; 5(1):8-20. PubMed ID: 18640078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
    Endoh T; Ohtsuki T
    Adv Drug Deliv Rev; 2009 Jul; 61(9):704-9. PubMed ID: 19383521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S; Morris M; Heitz F; Divita G
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides.
    Fischer R; Fotin-Mleczek M; Hufnagel H; Brock R
    Chembiochem; 2005 Dec; 6(12):2126-42. PubMed ID: 16254940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C; Nielsen HM
    Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.
    Meade BR; Dowdy SF
    Discov Med; 2009 Dec; 8(43):253-6. PubMed ID: 20040280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.
    Mäe M; Langel U
    Curr Opin Pharmacol; 2006 Oct; 6(5):509-14. PubMed ID: 16860608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA conjugate delivery systems.
    Jeong JH; Mok H; Oh YK; Park TG
    Bioconjug Chem; 2009 Jan; 20(1):5-14. PubMed ID: 19053311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of cell-penetrating peptides as a tool for gene regulation.
    Järver P; Langel U
    Drug Discov Today; 2004 May; 9(9):395-402. PubMed ID: 15081956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin-derived peptide carriers: mechanisms and application.
    Rennert R; Neundorf I; Beck-Sickinger AG
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):485-98. PubMed ID: 18160173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain.
    Kim J; Lee SH; Choe J; Park TG
    J Gene Med; 2009 Sep; 11(9):804-12. PubMed ID: 19569061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brief introduction to cell-penetrating peptides.
    Lundberg P; Langel U
    J Mol Recognit; 2003; 16(5):227-33. PubMed ID: 14523933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.